NYSE:PBYI

Puma Biotechnology Stock Predictions

etoro logo Buy PBYI
*Your capital is at risk
$6.81
-0.170 (-2.44%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

PBYI Prediction Chart

PBYI Predictions History

Latest community submissions for PBYI.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Mar 6, 2019 $37.22 +1.53% $36.66 X 98.50% 0
Gp Gp Merchant @Gp.98898
Mar 6, 2019 $42.07 +14.76% $36.66 X 85.20% 0
Mar 6, 2019 $38.93 +6.19% $36.66 X 93.80% 0
Mar 6, 2019 $42.00 +14.57% $36.66 X 85.40% 0
bbullish2 bbullish2 Merchant @bbullish2.7792
Feb 2, 2018 $65.11 +1.18% $64.35 X 98.80% 1
Metallica Metallica @Metallica.18524
Feb 2, 2018 $66.92 +3.99% $64.35 X 96.00% 0
JS JS Pro
Nov 14, 2017 $101.66 +1.46% $100.20 X 98.50% 1
Nov 14, 2017 $103.45 +3.24% $100.20 X 96.80% 0
Nov 14, 2017 $100.49 +0.29% $100.20 X 99.70% 4
Nov 14, 2017 $101.49 +1.29% $100.20 X 98.70% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for PBYI with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT PUMA BIOTECHNOLOGY INC
Puma Biotechnology
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advance...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE